Glenmark Pharmaceuticals has informed that it enclosed a press release titled ‘Glenmark Pharmaceuticals Announces Launch of Nebzmart® GFB Smartules® and Glenmark Airz® FB Smartules®, World’s First Nebulized Triple Therapy for COPD’.
The above information is a part of company’s filings submitted to BSE.